8-K Announcements
6Material company update
Apr 30, 2026·SEC
Material company update
Apr 30, 2026·SEC
Material company update
Apr 1, 2026·SEC
OrthoPediatrics Corp.(KIDS)Earnings, Financials & Key Ratios
KIDS•NASDAQ
$17.12
$433M mkt cap·Price updated May 6, 2026
AboutOrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.Show more
- Revenue$236M+15.4%
- EBITDA-$8M+25.8%
- Net Income-$40M-4.8%
- EPS (Diluted)-1.69-3.0%
- Gross Margin73.05%+0.6%
- EBITDA Margin-3.28%+35.7%
- Operating Margin-12.27%+14.9%
- Net Margin-16.78%+9.2%
- ROE-11.31%-9.4%
- ROIC-5.31%+10.3%
- Debt/Equity0.29+26.4%
- Interest Coverage-4.86+56.9%
KIDS Key Insights
OrthoPediatrics Corp. (KIDS) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong 5Y sales CAGR of 27.2%
- ✓Trading at only 1.2x book value
✗Weaknesses
- ✗Negative free cash flow
- ✗Low quality earnings: Net income not backed by cash flow
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
KIDS Price & Volume
OrthoPediatrics Corp. (KIDS) stock price & volume — 10-year historical chart
Loading chart...
KIDS Growth Metrics
OrthoPediatrics Corp. (KIDS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years22.52%
5 Years27.16%
3 Years24.56%
TTM14.52%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM2.46%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM4%
Return on Capital
10 Years-10.18%
5 Years-6.82%
3 Years-6.74%
Last Year-6.43%
KIDS Recent Earnings
OrthoPediatrics Corp. (KIDS) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 9/12 qtrs (75%)●Beat Revenue 9/12 qtrs (75%)
Q2 2026Latest
Apr 30, 2026EPS
$0.42
Est $0.46
+7.7%
Revenue
$59M
Est $58M
+1.8%
Q1 2026
Feb 26, 2026EPS
$0.26
Est $0.37
+29.7%
Revenue
$62M
Est $60M
+2.4%
Q4 2025
Oct 28, 2025EPS
$0.24
Est $0.26
+7.7%
Revenue
$61M
Est $59M
+3.3%
Q3 2025
Aug 5, 2025EPS
$0.11
Est $0.17
+35.3%
Revenue
$61M
Est $61M
-0.5%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 30, 2026 | $0.42vs $0.46+7.7% | $59Mvs $58M+1.8% |
| Q1 2026 | Feb 26, 2026 | $0.26vs $0.37+29.7% | $62Mvs $60M+2.4% |
| Q4 2025 | Oct 28, 2025 | $0.24vs $0.26+7.7% | $61Mvs $59M+3.3% |
| Q3 2025 | Aug 5, 2025 | $0.11vs $0.17+35.3% | $61Mvs $61M-0.5% |
Based on last 12 quarters of dataView full earnings history →
KIDS Peer Comparison
OrthoPediatrics Corp. (KIDS) competitors in Orthopedics, spine, and sports medicine — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 ATEC | 1.06B | 6.99 | -7.28 | 24.95% | -21.07% | -141.88% | 17.21 | |
 XTNT | 80.8M | 0.58 | -4.81 | 28.44% | 1.32% | 3.77% | 0.82 | |
 GMED | 12.07B | 89.22 | 22.76 | 16.65% | 18.3% | 12.4% | 0.03 | |
 ZBH | 16.22B | 82.83 | 23.33 | 7.2% | 9.05% | 5.77% | 0.59 | |
 SYK | 111.96B | 292.33 | 34.80 | 11.16% | 12.92% | 15.04% | 0.66 | |
 MDXG | 543.76M | 3.66 | 11.44 | 19.99% | 7.88% | 12.86% | 0.09 | |
 OFIX | 489.36M | 12.19 | -5.35 | 2.85% | -7.27% | -13.44% | 0.51 | |
 NVCR | 1.88B | 16.50 | -13.52 | 8.28% | -25.66% | -50.82% | 0.85 |
Compare KIDS vs Peers
OrthoPediatrics Corp. (KIDS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
KIDS Income Statement
OrthoPediatrics Corp. (KIDS) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 45.62M | 57.56M | 72.55M | 71.08M | 98.05M | 122.29M | 148.73M | 204.73M | 236.35M | 243.3M |
| Revenue Growth % | 22.31% | 26.17% | 26.05% | -2.03% | 37.95% | 24.72% | 21.62% | 37.65% | 15.45% | 14.52% |
| Cost of Goods Sold | 11.17M | 14.88M | 17.93M | 16.05M | 24.65M | 31.63M | 37.48M | 56.13M | 63.69M | 65.51M |
| COGS % of Revenue | 24.48% | 25.85% | 24.72% | 22.58% | 25.14% | 25.86% | 25.2% | 27.42% | 26.95% | - |
| Gross Profit | 34.45M▲ 0% | 42.68M▲ 23.9% | 54.62M▲ 28.0% | 55.03M▲ 0.8% | 73.4M▲ 33.4% | 90.66M▲ 23.5% | 111.25M▲ 22.7% | 148.6M▲ 33.6% | 172.66M▲ 16.2% | 177.79M▲ 0% |
| Gross Margin % | 75.52% | 74.15% | 75.28% | 77.42% | 74.86% | 74.14% | 74.8% | 72.58% | 73.05% | 73.07% |
| Gross Profit Growth % | 30.66% | 23.89% | 27.97% | 0.75% | 33.38% | 23.51% | 22.71% | 33.57% | 16.19% | - |
| Operating Expenses | 40.92M | 52.23M | 63.7M | 81.79M | 91.43M | 116.06M | 138M | 178.12M | 201.66M | 207.15M |
| OpEx % of Revenue | 89.7% | 90.75% | 87.79% | 115.07% | 93.25% | 94.91% | 92.79% | 87% | 85.32% | - |
| Selling, General & Admin | 37.5M | 47.5M | 57.95M | 70.17M | 85.73M | 104M | 126.12M | 167.09M | 192.56M | 195.2M |
| SG&A % of Revenue | 82.2% | 82.53% | 79.87% | 98.72% | 87.44% | 85.04% | 84.8% | 81.61% | 81.47% | - |
| Research & Development | 3.42M | 4.73M | 5.75M | 5.27M | 5.54M | 8.45M | 10.89M | 11.03M | 9.1M | 8.98M |
| R&D % of Revenue | 7.5% | 8.22% | 7.92% | 7.42% | 5.65% | 6.91% | 7.33% | 5.39% | 3.85% | - |
| Other Operating Expenses | 30K | -217K | 0 | 6.34M | 150K | 3.61M | 985K | 0 | 0 | 1000K |
| Operating Income | -6.47M▲ 0% | -9.55M▼ 47.6% | -9.08M▲ 5.0% | -26.75M▼ 194.8% | -18.02M▲ 32.6% | -25.4M▼ 40.9% | -26.75M▼ 5.3% | -29.52M▼ 10.4% | -29M▲ 1.8% | -29.36M▲ 0% |
| Operating Margin % | -14.19% | -16.6% | -12.51% | -37.64% | -18.38% | -20.77% | -17.99% | -14.42% | -12.27% | -12.07% |
| Operating Income Growth % | -5.63% | -47.61% | 4.98% | -194.76% | 32.63% | -40.92% | -5.32% | -10.35% | 1.77% | - |
| EBITDA | -4.07M | -6.66M | -4.44M | -18.75M | -7.34M | -12.3M | -9.37M | -10.44M | -7.75M | -13.29M |
| EBITDA Margin % | -8.91% | -11.57% | -6.12% | -26.37% | -7.49% | -10.06% | -6.3% | -5.1% | -3.28% | -5.46% |
| EBITDA Growth % | 3.74% | -63.78% | 33.33% | -322.09% | 60.82% | -67.48% | 23.85% | -11.48% | 25.76% | 22.57% |
| D&A (Non-Cash Add-back) | 2.4M | 2.89M | 4.64M | 8.01M | 10.68M | 13.1M | 17.39M | 19.08M | 21.25M | 16.07M |
| EBIT | -6.44M | -9.77M | -9.15M | -30.25M | -17.87M | -21.79M | -25.77M | -29.52M | -29.13M | -28M |
| Net Interest Income | -2.49M | -2.25M | -3.54M | -3.41M | -2.25M | -2.42M | 198K | -2.62M | -6M | -5.04M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 198K | 0 | 0 | 0 |
| Interest Expense | 2.49M | 2.25M | 3.54M | 3.41M | 2.25M | 2.42M | 0 | 2.62M | 6M | 5.04M |
| Other Income/Expense | -2.46M | -2.47M | -3.61M | -6.91M | 636K | 21.71M | 5.44M | -12.41M | -10.19M | -10.22M |
| Pretax Income | -8.93M▲ 0% | -12.03M▼ 34.6% | -12.69M▼ 5.5% | -33.67M▼ 165.4% | -17.39M▲ 48.4% | -3.69M▲ 78.8% | -21.31M▼ 477.7% | -41.93M▼ 96.7% | -39.19M▲ 6.5% | -39.58M▲ 0% |
| Pretax Margin % | -19.58% | -20.89% | -17.48% | -47.37% | -17.73% | -3.02% | -14.33% | -20.48% | -16.58% | -16.27% |
| Income Tax | 0 | 0 | 0 | -723K | -1.13M | -4.95M | -338K | -4.11M | 460K | 93K |
| Effective Tax Rate % | 0% | 0% | 0% | 2.15% | 6.49% | 134.1% | 1.59% | 9.8% | -1.17% | -0.23% |
| Net Income | -8.93M▲ 0% | -12.03M▼ 34.6% | -13.73M▼ 14.2% | -32.94M▼ 139.9% | -16.26M▲ 50.6% | 1.26M▲ 107.7% | -20.97M▼ 1767.2% | -37.82M▼ 80.3% | -39.65M▼ 4.8% | -39.68M▲ 0% |
| Net Margin % | -19.58% | -20.89% | -18.93% | -46.35% | -16.58% | 1.03% | -14.1% | -18.47% | -16.78% | -16.31% |
| Net Income Growth % | -35.91% | -34.63% | -14.19% | -139.92% | 50.64% | 107.74% | -1767.25% | -80.33% | -4.83% | 2.46% |
| Net Income (Continuing) | -8.93M | -12.03M | -12.69M | -32.94M | -16.26M | 1.26M | -20.97M | -37.82M | -39.65M | -39.68M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.85▲ 0% | -0.96▲ 48.1% | -1.18▼ 22.9% | -1.82▼ 54.2% | -0.84▲ 53.8% | 0.06▲ 107.0% | -0.92▼ 1659.3% | -1.64▼ 78.3% | -1.69▼ 3.0% | -1.68▲ 0% |
| EPS Growth % | -112.64% | 48.11% | -22.92% | -54.24% | 53.85% | 107.02% | -1659.32% | -78.26% | -3.05% | 4% |
| EPS (Basic) | -1.85 | -0.96 | -1.18 | -1.82 | -0.84 | 0.06 | -0.92 | -1.64 | -1.69 | - |
| Diluted Shares Outstanding | 4.82M | 12.57M | 14.62M | 18.06M | 19.27M | 20.95M | 22.68M | 23.08M | 23.46M | 23.69M |
| Basic Shares Outstanding | 4.82M | 12.57M | 14.62M | 18.06M | 19.27M | 20.7M | 22.68M | 23.08M | 23.46M | 23.69M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
KIDS Balance Sheet
OrthoPediatrics Corp. (KIDS) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 69.56M | 97.16M | 128.06M | 158.43M | 133.65M | 226.72M | 226.5M | 237.17M | 256.42M | 245.87M |
| Cash & Short-Term Investments | 42.58M | 60.69M | 70.78M | 85.27M | 54.91M | 118.29M | 80.31M | 68.83M | 60.85M | 48.81M |
| Cash Only | 42.58M | 60.69M | 70.78M | 30.13M | 9.01M | 8.99M | 31.05M | 43.82M | 19.56M | 12.19M |
| Short-Term Investments | 0 | 0 | 0 | 55.14M | 45.9M | 109.3M | 49.25M | 25.01M | 41.3M | 36.62M |
| Accounts Receivable | 5.6M | 9.5M | 16.57M | 17.55M | 17.94M | 24.8M | 34.62M | 42.36M | 53.84M | 54.43M |
| Days Sales Outstanding | 44.83 | 60.25 | 83.35 | 90.12 | 66.79 | 74.02 | 84.95 | 75.52 | 83.14 | 80.01 |
| Inventory | 20.55M | 25.71M | 38M | 52.99M | 57.57M | 78.19M | 105.85M | 117M | 133.79M | 134.02M |
| Days Inventory Outstanding | 671.35 | 630.65 | 773.43 | 1.21K | 852.58 | 902.34 | 1.03K | 760.87 | 766.77 | 726.94 |
| Other Current Assets | 831K | 0 | 1.25M | 2.62M | 3.23M | 1.47M | 5.72M | 1.96M | 7.94M | 8.61M |
| Total Non-Current Assets | 12.74M | 14.95M | 66.51M | 166.4M | 174.75M | 201.01M | 212.25M | 236.04M | 252.21M | 256.32M |
| Property, Plant & Equipment | 10.39M | 12.77M | 21.35M | 27.23M | 28.52M | 34.29M | 41.05M | 58.83M | 49.55M | 48.55M |
| Fixed Asset Turnover | 4.39x | 4.51x | 3.40x | 2.61x | 3.44x | 3.57x | 3.62x | 3.48x | 4.77x | 4.81x |
| Goodwill | 0 | 0 | 26.18M | 70.51M | 72.35M | 86.82M | 83.7M | 93.84M | 109.27M | 115.17M |
| Intangible Assets | 2.35M | 2.18M | 18.97M | 64.25M | 69.76M | 79.9M | 84.56M | 81.18M | 77.71M | 63.8M |
| Long-Term Investments | 0 | 0 | 53.26M | 0 | 0 | 189.52M | 1.85M | 2.18M | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | -54.1M | 0 | 0 | -195.48M | 1.08M | 0 | 15.68M | 72.01M |
| Total Assets | 82.3M▲ 0% | 112.11M▲ 36.2% | 194.56M▲ 73.6% | 324.83M▲ 67.0% | 308.4M▼ 5.1% | 427.73M▲ 38.7% | 438.75M▲ 2.6% | 473.21M▲ 7.9% | 508.63M▲ 7.5% | 502.19M▲ 0% |
| Asset Turnover | 0.55x | 0.51x | 0.37x | 0.22x | 0.32x | 0.29x | 0.34x | 0.43x | 0.46x | 0.48x |
| Asset Growth % | 168.29% | 36.21% | 73.56% | 66.95% | -5.06% | 38.69% | 2.58% | 7.86% | 7.49% | 32.04% |
| Total Current Liabilities | 9.47M | 9.22M | 13.66M | 35.03M | 29.71M | 30.87M | 41.67M | 33.96M | 46.2M | 47.18M |
| Accounts Payable | 5.5M | 3.97M | 6.47M | 10.04M | 9.32M | 11.15M | 12.65M | 8.91M | 18.79M | 19.7M |
| Days Payables Outstanding | 179.56 | 97.41 | 131.63 | 228.32 | 138.1 | 128.67 | 123.19 | 57.93 | 107.67 | 81.26 |
| Short-Term Debt | 113K | 118K | 124K | 12.36M | 13M | 144K | 152K | 160K | 170K | 172K |
| Deferred Revenue (Current) | 2.9M | 3.55M | 4.35M | 0 | 0 | 5.95M | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 954K | 1.58M | -1.63M | 8.09M | 2.04M | 6.88M | 7.39M | 8.89M | 16.64M | 27.31M |
| Current Ratio | 7.35x | 10.54x | 9.37x | 4.52x | 4.50x | 7.34x | 5.44x | 6.98x | 5.55x | 5.55x |
| Quick Ratio | 5.18x | 7.75x | 6.59x | 3.01x | 2.56x | 4.81x | 2.90x | 3.54x | 2.65x | 2.65x |
| Cash Conversion Cycle | 536.61 | 593.48 | 725.15 | 1.07K | 781.27 | 847.69 | 992.63 | 778.46 | 742.25 | 725.69 |
| Total Non-Current Liabilities | 25.34M | 21.16M | 38.54M | 55.03M | 53.32M | 18.21M | 20.05M | 84.68M | 115.84M | 69.11M |
| Long-Term Debt | 25.34M | 21.16M | 26.07M | 13.83M | 15.22M | 763K | 9.91M | 72.96M | 99.82M | 48.31M |
| Capital Lease Obligations | 0 | 0 | 63K | 323K | 293K | 0 | 0 | 5.66M | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | -63K | 10.17M | 8.9M | 5.95M | 5.48M | 0 | 3.58M | 14.27M |
| Other Non-Current Liabilities | 0 | 0 | 0 | 30.71M | 28.91M | 11.49M | 4.66M | 6.06M | 12.44M | 46.74M |
| Total Liabilities | 34.81M | 30.37M | 52.2M | 90.06M | 83.03M | 49.08M | 61.72M | 118.64M | 162.03M | 116.3M |
| Total Debt | 25.45M | 21.27M | 26.25M | 26.52M | 28.51M | 907K | 10.06M | 80.9M | 99.99M | 48.48M |
| Net Debt | -17.13M | -39.42M | -44.52M | -3.62M | 19.5M | -8.08M | -21M | 37.08M | 80.43M | 36.29M |
| Debt / Equity | 0.54x | 0.26x | 0.18x | 0.11x | 0.13x | 0.00x | 0.03x | 0.23x | 0.29x | 0.29x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | -3.65x |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | -2.73x |
| Interest Coverage | -2.59x | -4.33x | -2.59x | -8.87x | -7.95x | -8.99x | - | -11.26x | -4.86x | -5.55x |
| Total Equity | 47.49M▲ 0% | 81.73M▲ 72.1% | 142.36M▲ 74.2% | 234.77M▲ 64.9% | 225.37M▼ 4.0% | 378.65M▲ 68.0% | 377.02M▼ 0.4% | 354.57M▼ 6.0% | 346.6M▼ 2.2% | 338.71M▲ 0% |
| Equity Growth % | 692.38% | 72.09% | 74.18% | 64.91% | -4% | 68.01% | -0.43% | -5.96% | -2.25% | -14.75% |
| Book Value per Share | 9.86 | 6.50 | 9.73 | 13.00 | 11.70 | 18.08 | 16.63 | 15.36 | 14.77 | 14.30 |
| Total Shareholders' Equity | 47.49M | 81.73M | 142.36M | 234.77M | 225.37M | 378.65M | 377.02M | 354.57M | 346.6M | 338.71M |
| Common Stock | 2K | 4K | 4K | 5K | 5K | 6K | 6K | 6K | 6K | 6K |
| Retained Earnings | -103.07M | -115.09M | -128.82M | -161.77M | -178.03M | -176.77M | -197.74M | -235.56M | -275.21M | -285.9M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 135K | -623K | -3K | 7.91M | 8.49M | -5.4M | -5.53M | -10.77M | -523K | -1.4M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
KIDS Cash Flow Statement
OrthoPediatrics Corp. (KIDS) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -7.22M | -15.58M | -17.77M | -18.53M | -13.06M | -21.77M | -27.05M | -27.05M | -4.85M | -4.85M |
| Operating CF Margin % | -15.82% | -27.07% | -24.49% | -26.07% | -13.32% | -17.8% | -18.18% | -13.21% | -2.05% | - |
| Operating CF Growth % | -544.95% | -115.92% | -14.03% | -4.28% | 29.5% | -66.62% | -24.26% | -0.01% | 82.07% | 412.22% |
| Net Income | -8.93M | -12.03M | -13.73M | -32.94M | -16.26M | 1.26M | -20.97M | -37.82M | -39.65M | -39.68M |
| Depreciation & Amortization | 2.4M | 2.89M | 4.67M | 8.01M | 10.68M | 13.1M | 17.39M | 19.08M | 21.12M | 21.79M |
| Stock-Based Compensation | 3.48M | 3.19M | 2.6M | 6.2M | 5.84M | 6.68M | 10.53M | 13.55M | 17.78M | 17.9M |
| Deferred Taxes | 0 | 0 | -144K | -723K | -1.13M | -5.03M | -1.16M | -4.74M | -153K | -663K |
| Other Non-Cash Items | 12.25M | 19.09M | 210K | 5.92M | 354K | -20.01M | -623K | 5.82M | 6.84M | 4.66M |
| Working Capital Changes | -4.17M | -9.63M | -11.38M | -4.99M | -12.55M | -17.76M | -32.2M | -22.93M | -10.79M | -7.99M |
| Change in Receivables | -1.5M | -3.8M | -5.82M | -451K | -466K | -3.98M | -9.72M | -4.75M | -9.37M | -8.05M |
| Change in Inventory | -4.41M | -4.8M | -9.77M | -12.07M | -5.05M | -16.94M | -26.28M | -13.2M | -8.47M | -6.42M |
| Change in Payables | 1.95M | -1.52M | 2.4M | 3.07M | -567K | -209K | 1.49M | -4.28M | 8.17M | 3.66M |
| Cash from Investing | -6.54M | -5.96M | -61.92M | -69.69M | -7.41M | -113.37M | 41.68M | -13.16M | -43.63M | -41.43M |
| Capital Expenditures | -6.54M | -5.46M | -12.09M | -11.3M | -16.01M | -10.03M | -16.88M | -14.26M | -11.11M | -8.64M |
| CapEx % of Revenue | 14.34% | 9.49% | 16.66% | 15.9% | 16.33% | 8.2% | 11.35% | 6.97% | 4.7% | - |
| Acquisitions | 0 | 0 | -49.84M | -3.39M | 0 | -40.09M | -3.64M | -20.23M | -15.5M | -22.06M |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -1.34M | -502K | 0 | -796K | -650K | 0 | -2.11M | -2.88M | 0 | 1.29M |
| Cash from Financing | 54.73M | 39.66M | 91.02M | 46.73M | 6K | 135.97M | 7.3M | 53.13M | 23.98M | 23.49M |
| Debt Issued (Net) | 7.91M | -4.18M | 29.88M | -25.13M | -131K | -137K | 9.28M | 56.54M | 23.98M | 24.1M |
| Equity Issued (Net) | 52.78M | 43.42M | 60M | 70.21M | 137K | 139.28M | 21K | 0 | 0 | 0 |
| Dividends Paid | -5.96M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -990K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 410K | 1.14M | 1.65M | 0 | -3.17M | -2M | -3.41M | 0 | -614K |
| Net Change in Cash | 40.97M▲ 0% | 18.11M▼ 55.8% | 11.34M▼ 37.4% | -41.9M▼ 469.6% | -21.13M▲ 49.6% | 1.46M▲ 106.9% | 22.57M▲ 1449.8% | 12.75M▼ 43.5% | -24.16M▼ 289.5% | -21.18M▲ 0% |
| Free Cash Flow | -13.76M▲ 0% | -21.05M▼ 52.9% | -29.86M▼ 41.9% | -29.83M▲ 0.1% | -29.07M▲ 2.5% | -31.8M▼ 9.4% | -46.03M▼ 44.8% | -41.31M▲ 10.3% | -15.96M▲ 61.4% | -12.63M▲ 0% |
| FCF Margin % | -30.16% | -36.56% | -41.15% | -41.97% | -29.65% | -26% | -30.95% | -20.18% | -6.75% | -5.19% |
| FCF Growth % | -134.31% | -52.94% | -41.86% | 0.08% | 2.53% | -9.37% | -44.76% | 10.25% | 61.36% | 65.77% |
| FCF per Share | -2.86 | -1.67 | -2.04 | -1.65 | -1.51 | -1.52 | -2.03 | -1.79 | -0.68 | -0.68 |
| FCF Conversion (FCF/Net Income) | 0.81x | 1.30x | 1.29x | 0.56x | 0.80x | -17.30x | 1.29x | 0.72x | 0.12x | 0.32x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
KIDS Key Ratios
OrthoPediatrics Corp. (KIDS) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -33.4% | -18.61% | -12.25% | -17.47% | -7.07% | 0.42% | -5.55% | -10.34% | -11.31% | -11.42% |
| Return on Invested Capital (ROIC) | -18.57% | -19.72% | -9.71% | -12.2% | -5.68% | -6.19% | -5.52% | -5.92% | -5.31% | -5.31% |
| Gross Margin | 75.52% | 74.15% | 75.28% | 77.42% | 74.86% | 74.14% | 74.8% | 72.58% | 73.05% | 73.07% |
| Net Margin | -19.58% | -20.89% | -18.93% | -46.35% | -16.58% | 1.03% | -14.1% | -18.47% | -16.78% | -16.31% |
| Debt / Equity | 0.54x | 0.26x | 0.18x | 0.11x | 0.13x | 0.00x | 0.03x | 0.23x | 0.29x | 0.29x |
| Interest Coverage | -2.59x | -4.33x | -2.59x | -8.87x | -7.95x | -8.99x | - | -11.26x | -4.86x | -5.55x |
| FCF Conversion | 0.81x | 1.30x | 1.29x | 0.56x | 0.80x | -17.30x | 1.29x | 0.72x | 0.12x | 0.32x |
| Revenue Growth | 22.31% | 26.17% | 26.05% | -2.03% | 37.95% | 24.72% | 21.62% | 37.65% | 15.45% | 14.52% |
KIDS SEC Filings & Documents
OrthoPediatrics Corp. (KIDS) SEC filings — annual & quarterly reports (10-K, 10-Q)
KIDS Frequently Asked Questions
OrthoPediatrics Corp. (KIDS) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
OrthoPediatrics Corp. (KIDS) reported $243.3M in revenue for fiscal year 2025. This represents a 927% increase from $23.7M in 2014.
OrthoPediatrics Corp. (KIDS) grew revenue by 15.4% over the past year. This is strong growth.
OrthoPediatrics Corp. (KIDS) reported a net loss of $39.7M for fiscal year 2025.
Dividend & Returns
OrthoPediatrics Corp. (KIDS) has a return on equity (ROE) of -11.3%. Negative ROE indicates the company is unprofitable.
OrthoPediatrics Corp. (KIDS) had negative free cash flow of $12.6M in fiscal year 2025, likely due to heavy capital investments.
Explore More KIDS
OrthoPediatrics Corp. (KIDS) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates